Gibson SOLA Platform
Your constructs, your timeline
Learn why leading biotech and pharma teams are bringing DNA synthesis in-house — and how it’s accelerating their research.
The traditional model of outsourcing DNA synthesis is breaking down. Backlogs, shipping delays, security concerns, and a lack of visibility are leaving too many scientists stuck in a holding pattern. But there's a better way.
The Gibson SOLA™ Platform enables overnight, high-fidelity DNA synthesis in your own lab. This white paper explores how Gibson SOLA empowers you to:
- Cut synthesis time from weeks to a single day
- Safeguard proprietary sequences by eliminating third-party transfers
- Iterate faster with real-time construct design and synthesis logs
- Boost yield and fidelity with block-based enzymatic assembly
